Scarica l'app Stockscreener
161.79
0.27%
-0.43
Dopo l'orario di chiusura:
161.79
Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
14.21%
218.38
|
191.20 | 196.00 | 170.99 | 150.04 |
Selling, General, and Administrative
|
12.51%
208.14
|
185.00 | - | - | - |
| Interest Income/Expense |
203.49%
-3.20
|
3.092 | -3.209 | -3.375 | -4.086 |
| Costs And Expenses |
5.29%
268.02
|
254.56 | 222.96 | 217.10 | 186.76 |
| Operating Income/Loss |
21.64%
-49.65
|
-63.36 | -26.96 | -46.11 | -36.71 |
| Income/Loss From Continuing Operations Before Tax |
20.69%
-51.19
|
-64.54 | -28.13 | -47.23 | -48.93 |
| Income Tax Expense/Benefit |
0.128
|
- | 0.43 | - | -0.96 |
| Net Income/Loss |
20.50%
-51.31
|
-64.54 | -28.56 | -47.23 | -47.97 |
| Basic Average Shares |
1.17%
51.80
|
51.20 | 0.298 | 50.02 | 49.44 |
| Diluted Average Shares |
1.17%
51.80
|
51.20 | 0.298 | 50.02 | 49.44 |
| Basic Earnings Per Share |
21.43%
-0.99
|
-1.26 | -0.55 | -0.94 | -0.97 |
| Diluted Earnings Per Share |
21.43%
-0.99
|
-1.26 | -0.55 | -0.94 | -0.97 |
3.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):